Moreover, we further explored the potential of EGFR internalization to characterize the advanced prostate cancer cells and developed a 3D inward movement assay that combines 3D single-particle tracking and 2P scanning imaging to monitor the internalization of fluorescently labeled EGFR in living cells [44] (Figure S2, Method S3–S6). Here, EGFR is linked to prostate carcinoma.